148 related articles for article (PubMed ID: 10903068)
1. Transforming growth factor-beta1 and prostate cancer.
Wikström P; Bergh A; Damber JE
Scand J Urol Nephrol; 2000 Apr; 34(2):85-94. PubMed ID: 10903068
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor-beta1 in prostate cancer.
Wikström P; Damber J; Bergh A
Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
[TBL] [Abstract][Full Text] [Related]
3. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
4. Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients.
Wikström P; Westin P; Stattin P; Damber JE; Bergh A
Prostate; 1999 Mar; 38(4):268-77. PubMed ID: 10075006
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.
Wikström P; Stattin P; Franck-Lissbrant I; Damber JE; Bergh A
Prostate; 1998 Sep; 37(1):19-29. PubMed ID: 9721065
[TBL] [Abstract][Full Text] [Related]
9. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
10. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
12. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
13. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
14. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells.
Li Z; Chen Y; Cao D; Wang Y; Chen G; Zhang S; Lu J
Endocrinology; 2006 Nov; 147(11):5259-67. PubMed ID: 16887915
[TBL] [Abstract][Full Text] [Related]
18. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
19. TGF-betal/Smad signaling in prostate cancer.
Bello-DeOcampo D; Tindall DJ
Curr Drug Targets; 2003 Apr; 4(3):197-207. PubMed ID: 12643470
[TBL] [Abstract][Full Text] [Related]
20. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
